GeneFluidics, Inc.
PrivateLast Round
Series A
Nov 4, 2022
Total Funding Raised
$15.78M
Company Overview
GeneFluidics, Inc. operates in Healthcare & Life Sciences and is based in Irwindale, California. Its latest recorded funding round was a Grant round in September 2021.
GeneFluidics, Inc. is a biotechnology company that develops rapid molecular diagnostic platforms for the detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneFluidics, Inc. Comparables
Compare GeneFluidics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avails Medical | 80% | |
| Pattern Bioscience | 80% | |
| QuantaMatrix Inc. | 79% |
For institutional investors. Book with your work email.
GeneFluidics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 4, 2022 | ||||
| Grant | Sep 30, 2021 | ||||
| Grant | Sep 30, 2020 | ||||
| Grant | Sep 30, 2019 | ||||
| Grant | Sep 30, 2018 | ||||
Grant | Sep 30, 2017 |
For institutional investors. Book with your work email.
GeneFluidics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Bradbury Asset Management (Hong Kong) Limited | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2022
Raised Series A round with Bradbury Asset Management.
- Sep 30, 2021
$962K grant received from U.S. Department of Health and Human Services.
For institutional investors. Book with your work email.
GeneFluidics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GeneFluidics, Inc.'s valuation, stock price, and market status.
Is GeneFluidics, Inc. a public or private company?
GeneFluidics, Inc. is a private company.
What is the current stock price of GeneFluidics, Inc.?
GeneFluidics, Inc. is a private company, so its shares have no public market price. Caplight tracks GeneFluidics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneFluidics, Inc. worth (valuation)?
Valuation information for GeneFluidics, Inc. is not publicly available.
Can I buy GeneFluidics, Inc. stock?
GeneFluidics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneFluidics, Inc.'s last funding round?
GeneFluidics, Inc.'s most recent funding round was Series A on November 4, 2022.
Who are the main investors in GeneFluidics, Inc.?
Key investors in GeneFluidics, Inc. include U.S. Department of Health and Human Services, Bradbury Asset Management (Hong Kong) Limited.
Will GeneFluidics, Inc. IPO soon?
No public IPO plans have been announced for GeneFluidics, Inc..
How can I track GeneFluidics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in GeneFluidics, Inc.'s shares on secondary markets.